| III-28 Nina Hanke Physiologically-based pharmacokinetic (PBPK) modeling of alfentanil as a CYP3A4 victim drug Thursday 09:50-11:20 |
| III-28 Nina Hanke Physiologically-based pharmacokinetic (PBPK) modeling of alfentanil as a CYP3A4 victim drug Thursday 09:50-11:20 |